New Key Statistics Module, Z-Score and F-Score
NAS:ABCL Key Ratios
Market Cap $ M | 769.08 |
Enterprise Value $ M | 170.78 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.69 |
Price/Sales | 22.89 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 33.00 |
EPS (TTM) $ | -0.54 |
Beneish M-Score | -1.93 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.67 |
EV-to-EBITDA | -0.87 |
PEG | -- |
Shares Outstanding M | 294.67 |
Net Margin (%) | -463.77 |
Operating Margin % | -775.99 |
Pre-tax Margin (%) | -540.95 |
Quick Ratio | 10.96 |
Current Ratio | 10.96 |
ROA % (ttm) | -10.34 |
ROE % (ttm) | -13.28 |
ROIC % (ttm) | -33.19 |
Dividend Yield % | -- |
Altman Z-Score | 1.93 |
ABCL Number of Guru Trades
ABCL Volume of Guru Trades
Gurus Latest Trades with NAS:ABCL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABCL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AbCellera Biologics Inc Insider Transactions
No Available Data
News about NAS:ABCL
Total 0- 1